Coriolis Pharma invites you to their event

Every particle matters - Identify visible and subvisible particles in your biologic and gene and cell therapy drug product

About this event

Particles in the visible and subvisible size range can appear in (bio)pharmaceutical samples and drug products during all stages of development and even after market approval. The presence of particles can indicate an insufficient stability of the active pharmaceutical ingredient or issues with the production process and can negatively influence the safety and efficacy of the medicine. 

In this webinar we will talk about tools and methods for particle identification and characterization in biologics and gene and cell therapy drug products.


  • What type of particles can be present in a biologic or gene & cell therapy product?
  • What needs to be characterized and how? 
  • Where can particle identification provide added value to your drug product development or troubleshooting?

Hosted by

  • Guest speaker
    Tim Menzen CTO @ Coriolis Pharma

  • Guest speaker
    Daniel Demminger Expert Scientist @ Coriolis Pharma

Coriolis Pharma

Formulating Innovation

Coriolis Pharma is a globally operating contract research and development organization and one of the world leaders in formulation research and development of biopharmaceuticals including vaccines and ATMPs.